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Abstract
The ribosomal protein L22 is a component of the 60S eukaryotic ribosomal subunit. As an RNA-binding protein, it has been
shown to interact with both cellular and viral RNAs including 28S rRNA and the Epstein-Barr virus encoded RNA, EBER-1. L22
is localized to the cell nucleus where it accumulates in nucleoli. Although previous studies demonstrated that a specific
amino acid sequence is required for nucleolar localization, the RNA-binding domain has not been identified. Here, we
investigated the hypothesis that the nucleolar accumulation of L22 is linked to its ability to bind RNA. To address this
hypothesis, mutated L22 proteins were generated to assess the contribution of specific amino acids to RNA binding and
protein localization. Using RNA-protein binding assays, we demonstrate that basic amino acids 80–93 are required for high
affinity binding of 28S rRNA and EBER-1 by L22. Fluorescence localization studies using GFP-tagged mutated L22 proteins
further reveal that basic amino acids 80–93 are critical for nucleolar accumulation and for incorporation into ribosomes. Our
data support the growing consensus that the nucleolar accumulation of ribosomal proteins may not be mediated by a
defined localization signal, but rather by specific interaction with established nucleolar components such as rRNA.
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Introduction
Assembly of eukaryotic ribosomal subunits occurs in the cell
nucleolus whereribosomal proteins areassembled along with rRNA
by a myriad of processing and assembly factors (reviewed in: [1]).
The nucleolus is a dynamic structure, breaking down during mitosis
and reassembling around centers of rDNA transcription following
cell division [2]. Ribosomal proteins, which like other proteins are
translated in the cytoplasm, must be imported into the nucleus via
an active transport mechanism mediated by a nuclear localization
signal (NLS) and then transit to the nucleolus. While many
nucleolar proteins contain classical monopartite or bipartite NLSs
[3,4], Stuger, et al. proposed that eukaryotic ribosomal proteins
utilize a unique nuclear import pathway mediated by a novel
consensus NLS [5]. In contrast to nuclear import, the mechanism
by which ribosomal proteins accumulate in the nucleolus is not well
understood. A number of retroviral proteins are known to contain a
specific nucleolar targeting signal composed of basic amino acid
clusters, however this consensus sequence is not generally found in
cellular nucleolar proteins [6]. Because the nucleolus is not a
membrane-bound structure, it is presumed that nucleolar accumu-
lation occurs via interaction with established nucleolar components
such as rRNA [2]. While a number of studies have examined the
sequence requirements for the nucleolar localization of ribosomal
proteins [7–13], relatively few have examined rRNA binding as a
means for nucleolar accumulation [14–17].
The ribosomal protein L22, a component of the 60S ribosomal
subunit, has been characterized as an RNA-binding protein. Early
studies of L22 termed the protein EAP for EBER-associated protein
in reference to its interaction with a small viral RNA encoded by
Epstein-Barr virus (EBV) [18,19]. L22 is unique to eukaryotes and
its cellular function has yet to be clearly defined. Studies
demonstrating that partially reconstituted ribosomes lacking L22
are active for translation in vitro suggest that L22 may function in a
regulatory capacity and have extra-ribosomal functions [20]. This is
supported by recent evidence that germline disruption of the RPL22
gene in mice is not lethal whereas this is the case for other ribosomal
proteins [21,22]. L22 has been observed to bind both cellular and
viral RNAs [18,19,23–25]. Its interaction with the EBV-encoded
RNA EBER-1 has been well characterized by mutational analyses
which reveal that point mutations in the base paired nucleotides of
the stem as well as nucleotides in the loop of EBER-1 stem-loop III
significantly decrease binding by L22 in vitro [19]. Subsequent
studies have shown that L22 can bind three sites on EBER-1
encompassing portions of stem-loops I, III and IV [18,19,26,27].
The most frequently isolated cellular RNA sequence bound by L22
maps to stem-loop 7 of 28S rRNA [25,28]. Additional regions of
28SrRNA,aswell asregions of 18S rRNA,havealso been shown to
interact with L22 in vitro [25]. Comparison of RNA sequences
bound by L22 has allowed for the establishment of a consensus L22
binding site consisting of a stem-loop structure with a G-C base pair
at the base of the loop and a 5–7 nucleotide loop with a U residue at
the 39 end [25].
Although the accumulation of L22 in nucleoli has been
demonstrated and a specific amino acid sequence has been shown
to contribute to nucleolar localization [29], an RNA-binding
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binding and nucleolar accumulation been established. Here, we
investigated the sequences required for RNA binding and
nucleolar localization of L22 using RNA-binding assays and
fluorescence localization studies. We demonstrate that a specific
cluster of basic amino acids is critical for high affinity RNA
binding and for the nucleolar accumulation of L22, thereby linking
rRNA binding to nucleolar accumulation of this protein.
Results
L22 binds EBER-1 and 28S rRNA in vivo
To confirm previous reports [19,25–27] and establish that L22
interacts with both EBER-1 and 28S rRNA in vivo,w eu t i l i z e da
biotin-avidin affinity assay to isolate L22 and any associated RNA. In
this assay, a 17-amino acid biotin acceptor peptide (BAP)was fused to
the N-terminus of L22 and biotinylation was accomplished in vivo
using a co-expressed bacterial biotin ligase (BirA). 293T cells were
transientlyco-transfected with expression constructs encoding BAP or
BAP-L22, BirA, and EBER-1, EBER-2 or both EBERs. Following
UV crosslinking and lysis of cells, biotinylated proteins were captured
on avidinbeads and analyzed by immunoblot for the presence of L22
(Fig. 1A, top panel) and biotin (Fig. 1A, lower panel).After confirming
that BAP-L22 was efficiently biotinylated and successfully captured
on avidin beads, RNA associated with the isolated proteins was
extracted and detected by northern blot analysis.As shown in Fig. 1B,
while EBER-1 (lane 5) and 28S rRNA (lanes 5–6) were isolated along
with biotinylated BAP-L22, EBER-2 (lane 6) was not isolated.
Furthermore, none of these RNAs were isolated in the presence of
only BAP (lane 4) demonstrating that the observed binding was
specific for L22 and not an artifact of the BAP tag. These results
clearly demonstrate that L22 binds strongly to full-length EBER-1
and, to a lesser extent, endogenous 28S rRNA in vivo.
Clusters of basic amino acids are required for L22 to bind
to RNA
To define the amino acids of L22 required for RNA binding, we
generated a series of N-terminally fused GFP-L22 expression
constructs in which regions of L22 likely to be involved in RNA
binding were mutated (Fig. 2A). These mutations included several
clusters of basic amino acids chosen largely based on the
prediction that positively charged amino acids are likely to
interact with negatively charged nucleic acids. As depicted in
Fig. 2B, select lysine and arginine residues were mutated to
glutamic acid and aspartic acid residues or to alanine residues.
Furthermore, based on previous work by Shu-Nu et al. [29], two
additional constructs were generated in which either the N-
terminus (D1–9) or C-terminus (D120–128) was truncated. Protein
expression from each construct was confirmed following transient
transfection into 293T cells and subsequent immunoblot analysis
(Fig. 2C). While proteins of the predicted size were efficiently
expressed from the majority of constructs, m65 was consistently
expressed at reduced levels relative to wild-type L22 and the other
mutated L22 proteins. This is likely the result of reduced
transfection efficiency using this construct or potentially indicative
of cellular cytotoxicity or protein misfolding.
To determine if the amino acid substitutions and truncations
altered the ability of L22 to bind RNA, each mutated L22 protein
was tested for its ability to bind EBER-1 RNA via electrophoretic
mobility shift assay (EMSA). EBER-1 was chosen as the target RNA
for this assay as its interaction with L22 has been well characterized
and isofhighaffinity [19,25–27].Full-length EBER-1, inadditionto
Figure 1. L22 binds EBER-1 and 28S rRNA in vivo. (A) Expression and biotinylation of BAP-L22 in transiently transfected 293T cells. Transfected
cells were lysed and expression of BAP-L22 was verified by immunoblot with anti-L22 antibody (top panel). Successful biotinylation was confirmed by
immunoblot with HRP-conjugated streptavidin (bottom panel). Specific capture of biotinylated L22 was demonstrated by immunoblot analysis
following incubation of protein lysates with avidin agarose and stringent washing (bound). (B) Specific binding of EBER-1 and 28S rRNA by BAP-L22.
293T cells were transiently co-transfected with either BAP or BAP-L22 and EBERs, EBER-1, or EBER-2 as indicated. 48 hrs post-transfection, cells were
UV crosslinked and biotinylated L22 was isolated using avidin agarose, as above. RNA was isolated from both the supernatant and pellet of affinity
capture reactions. 2.5 mg RNA from each supernatant sample along with entire RNA sample from each pellet was analyzed by northern hybridization
using probes specific for EBER-1, EBER-2, and 28S rRNA, as indicated.
doi:10.1371/journal.pone.0005306.g001
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several other cellular proteins, making interpretation of results
somewhat complex [30–32]. Consequently, to evaluate the specific
interaction between L22 and EBER-1, we chose to use an RNA
oligonucleotide corresponding to stem-loop III (SL3) of EBER-1
which to date has been shown to interact only with L22.As shown in
Fig. 3A, a concentration-dependent mobility shift of SL3 probe was
observed when increasing amounts of protein lysate derived from
cells expressing GFP-L22 were added to binding reactions (lanes 3–
5).ThismobilityshiftwasnotseenusinglysatecontainingGFPalone
(lane 2), even at concentrations exceeding 20 mg of protein lysate
(data not shown). An additional faster migrating complex was also
observed in all protein-containing reactions (lanes 2–5, designated
‘‘E’’) and likely corresponds to a complex containing endogenous
L22. To confirm that GFP-L22 was present within the slower
mobility complexes formed with SL3, we performed antibody
supershift assays using anti-GFP antibody to alter the mobility of
GFP-L22 containing complexes. As demonstrated in Fig. 3B, while
addition of anti-GFP antibody did result in a supershifted complex
(lane 3, designated ‘‘SS’’), addition of a nonspecific control anti-
polyhistidine antibody did not alter the mobility of the shifted
complex (lane 4). The overall reduction in intensity of signal
observed in reactions containing anti-polyhistidine antibody may be
the result of nuclease contamination of the antibody solution,
however, we do not believe that this interfered with our ability to
visualize a supershifted complex had there been one as longer
exposures showed no evidence of any effect on the mobility of the
observed complexes. Additional confirmation of binding specificity
was obtained from competition experiments in which the wild-type,
but not a mutated, SL3 oligonucleotide effectively competed with
probe for L22 binding (compare 1006 SL3 with 1006 mSL3,
Fig.3B).Having established the specificityoftheinteractionbetween
GFP-L22 andSL3, we nexttestedthe RNA bindingcapacity of each
mutated L22 protein. As depicted in Fig. 3C, truncation of the nine
N-terminal amino acids (D N9, left panel), as well as specific
mutation oflysines13–16 (m13–16,rightpanel), hadnoeffecton the
ability of L22 to bind EBER-1 RNA. By contrast, mutations
introduced into basic amino acid clusters located at residues 80–84
and 88–93 completely abolished RNA binding (right panel).
Together, these results demonstrate that residues within the N-
Figure 2. Generation and characterization of wild-type and mutated L22 expression constructs. (A) Clusters of basic amino acids likely to
be involved in RNA binding were identified within the L22 amino acid sequence and are shown underlined with the basic residues highlighted in
bold font. The nine amino-terminal residues previously predicted to be the RNA-binding domain are also highlighted in bold [29]. (B) Location of
mutations introduced into L22 coding sequence. Constructs expressing L22 lacking either nine amino-terminal or eight carboxy-terminal residues are
designated D1–9 and D120–128, respectively. Point mutations generated in the basic amino acid clusters illustrated in (A) are shown relative to the
wild-type sequence (shown directly below the line) and designated by arrows above and below the line. For m80 and m88, constructs with K to E
mutations (and R to D) have been designated m80 and m88 while constructs with K to A mutations have been designated m80A and m88A. (C) N-
terminal GFP-L22 fusion constructs, depicted in (B), were transiently transfected into 293T cells followed by analysis of protein lysates for protein
expression by immunoblot using anti-GFP antibody. GAPDH served as a control for protein loading.
doi:10.1371/journal.pone.0005306.g002
L22 RNA Binding Domain
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5306terminal region are not required for RNA binding and establish that
basic amino acid residues located between 80–93 constitute the
primary RNA-binding domain of L22.
To obtain independent confirmation of our EMSA data and
evaluate the requirements for L22 to bind 28S rRNA, we
established a magnetic bead RNA-protein binding assay. In this
assay, full-length EBER-1 or 28S rRNA stem-loop 7 (SL7)
transcripts generated by in vitro transcription were annealed to
biotinylated DNA oligonucleotides complementary to the 39 end
of each transcript. These biotinylated nucleic acid complexes were
incubated with protein lysates and bound complexes were
captured on streptavidin magnetic beads and analyzed by
immunoblotting. As shown in Fig. 4, GFP-L22 and D1–9 were
captured on the magnetic bead column in the presence of both
EBER-1 (4A) and 28S rRNA (4B), as indicated by the band
present in column eluates. GFP alone was unable to bind either
RNA and was consequently not seen in column eluates. In
agreement with the results presented in Fig. 3, m13–16 was found
in the eluate in the presence of EBER-1, as was m65,
demonstrating that both proteins bound EBER-1. Furthermore,
as expected, mutation of basic residues 80–93 eliminated binding
of L22 to EBER-1 (Fig. 4A, lower panels). Occasionally, very weak
bands for these proteins were observed in column eluates.
However, given the strength of this binding relative to that seen
with wild-type and other mutated proteins and the results of our
EMSA experiments, this is likely attributable to nonspecific
interactions with the beads or RNA or possibly very weak affinity
for the RNA. Following assay validation, we next evaluated the
Figure 3. Clusters of basic amino acids mediate L22 binding to EBER-1. (A) Binding of GFP-L22 to stem-loop III of EBER-1 (SL3) was tested in
RNA EMSA experiments using increasing amounts of protein lysate (1, 5, and 20 mg) generated from 293T cells transfected with GFP-L22. 5 mgo f
control lysate expressing only GFP was used to assess nonspecific binding. Each 10 ml binding reaction contained 0.05 pmoles
32P end-labeled SL3
RNA oligonucleotide. Reactions were electrophoresed on 8% native polyacrylamide gels and visualized by autoradiography. (B) L22 binds specifically
to EBER-1. Binding specificity of L22 to SL3 was tested by antibody supershift and by competition with unlabeled oligonucleotides. 5 mg of GFP-L22
protein lysate was used in binding reactions. For antibody supershift experiments, 1 ml of anti-GFP or anti-polyhistidine (nonspecific control) antibody
was added to binding reactions. In competition experiments, 106 and 1006 unlabeled SL3 or mutated SL3 (mSL3) was added. (C) RNA binding
capacity of GFP-L22 containing basic residue mutations or truncation of the amino-terminus (left panel) or with internal point mutations (right panel)
was tested in RNA EMSA reactions, as described above. Amounts of each protein lysate used in binding reaction were determined by normalizing the
level of expression of each mutated L22 construct to the level of GFP-L22 in 5 mg total protein lysate. Abbreviations used are: FP=free probe,
NS=nonspecific, E=endogenous, GFP-L22=all specific shifts generated with wild-type or mutated GFP-L22 proteins, SS=supershift.
doi:10.1371/journal.pone.0005306.g003
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As expected, m13–16 and m65 were captured in this assay. By
contrast, m88, m88A and m80–93 were not found in the eluate,
clearly demonstrating that basic residues 88–93 are absolutely
critical for L22 to bind both EBER-1 and 28S rRNA. Somewhat
surprisingly, m80 and m80A were present in the eluate, although
m80 appeared to bind less well than m80A. Nevertheless, taken
together with the EBER-1 data, it is likely that residues 80–84
contribute to the binding affinity of L22 for both RNAs, although
perhaps to a lesser extent for 28s rRNA.
Loss of RNA binding capacity alters the subcellular
localization of L22
Several studies have established a link between the ability of
certain proteins to bind rRNA and the nucleolar targeting and
retention of these proteins (reviewed in: [5,33,34]). Given the
finding that L22 binds 28S rRNA, we pursued the hypothesis that
the interaction of L22 with 28S rRNA is essential for nucleolar
localization of L22. To validate our system, we first evaluated the
subcellular localization of unfused GFP, GFP-L22 (N-term), L22-
GFP (C-term), BAP-L22, GFP-L23, and fibrillarin (an endogenous
marker for nucleoli). While expression of GFP alone resulted in
diffuse nuclear and cytoplasmic fluorescence, L22 tagged at either
termini with GFP or BAP was localized to nucleoli (Fig. 5A). Of
note, L22 proteins expressed transiently in 293T and HeLa cells
typically displayed abundant nucleolar but little cytoplasmic
fluorescence, whereas stably expressed GFP-L22 was observed in
nucleoli and in the cytoplasm (Fig. 5A). We attribute this to the
high level of L22 expressed in transiently transfected cells, resulting
in intense nucleolar fluorescence which obscures the more diffuse
GFP fluorescence in the cytoplasm. This conclusion is supported
by the readily observable cytoplasmic fluorescence in stably
expressing cells where GFP-L22 is expressed at lower levels and
by the finding that a similar localization pattern is observed for
GFP-L23 transiently expressed in 293T cells (Fig. 5A). Further-
more, when cells transiently expressing GFP-L22 were fraction-
ated into nuclear (N) and cytoplasmic (C) fractions, GFP-L22
(upper band) was found in both fractions at levels equivalent to
those seen for endogenous L22, (lower band) supporting the
conclusion that GFP-L22 is abundantly present in the cytoplasm
(Fig. 5B). Additionally, expression of GFP-L22 did not alter the
localization of endogenous L22 as the fractionation pattern of L22
is equivalent in untransfected cells. To confirm that the inclusion
of a GFP tag on L22 does not interfere with the ability of GFP-L22
to be incorporated into ribosomes, we performed sucrose density
gradient analyses on cellular extracts from cells stably expressing
Figure 4. Mutation of residues 80–93 eliminates binding of L22 to multiple RNA substrates. The capacity of mutated L22 proteins to bind
to EBER-1 (A) and 28S rRNA (B) was determined by specific capture of proteins on biotinylated RNAs immobilized on streptavidin magnetic beads.
Protein lysates were generated from transiently transfected 293T cells and normalized for expression relative to wild-type GFP-L22. Total protein was
incubated with 100 pmoles of biotinylated RNA and complexes were captured on streptavidin magnetic bead columns. Column flow-thru and eluate
were subjected to SDS-PAGE and analyzed for GFP-L22 proteins by immunoblot using anti-GFP antibody. Protein lysate from cells transfected with
GFP alone was used as a control for nonspecific binding to beads or RNA.
doi:10.1371/journal.pone.0005306.g004
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concentrated in fractions 9–12 which, as illustrated by ethidium
bromide staining of electrophoresed RNA and by the polysome
profile shown in Fig. 5C, also contain 28S rRNA and correspond
to 60S ribosomal subunits. This fractionation pattern is equivalent
to that seen with endogenous L22 (lower band) in these cells. Thus,
we conclude that, despite the addition of a GFP tag, GFP-L22 is
efficiently targeted to nucleoli and incorporated into cytoplasmic
ribosomes.
Having established that the addition of GFP does not alter the
localization of wild-type L22 or its ability to be incorporated into
ribosomes and transported to the cytoplasm, we next evaluated
our panel of L22 mutations. As expected, given our hypothesis that
RNA binding and nucleolar localization are correlated, D1–9
which is capable of binding 28S rRNA was found to be localized to
nucleoli (Fig. 6A). An additional protein, D120–128, which is also
capable of binding 28S rRNA (data not shown), was found to be
similarly localized. Next, we investigated the consequence of
internal point mutations on L22 localization. A previous study
demonstrated that nuclear import of L22 depends on a classical
nuclear localization signal consisting of a string of four lysine
residues (13–16) preceded by a glycine residue [29]. In agreement
with this, while mutation of only two lysine residues in this
sequence (m14–15) resulted in increased nucleoplasmic and
reduced nucleolar fluorescence relative to wild-type L22, mutation
of all four lysine residues (m13–16) resulted in retention of L22 in
the cytoplasm (Fig. 6A). Having defined the requisite sequences for
nuclear entry of L22, we next evaluated the amino acid
requirement for nucleolar targeting and retention. In agreement
with our hypothesis, mutations which eliminated RNA binding
Figure 5. GFP-L22 is localized to nucleoli and incorporated into ribosomes. (A) The subcellular localization of wild-type L22 fusion proteins
and control proteins was analyzed by fluorescence microscopy following expression in 293T and HeLa cells. For transient expression, cells grown on
coverslips were transfected with 2 mg of the indicated expression construct, fixed after 48 hrs and visualized using a Zeiss Axiovert inverted
fluorescence microscope. HeLa-L22 cells stably express GFP-L22. BAP-L22 expression was visualized in transiently transfected HeLa cells following
staining with Alexa Fluor 488-conjugated streptavidin. Fibrillarin served as an endogenous nucleolar marker and was detected in HeLa cells using
anti-fibrillarin antibody and Alexa-conjugated secondary antibody. All coverslips were mounted in Vectashield plus DAPI. Bar equals 10 mm. (B)
Nuclear (N) and cytoplasmic (C) fractions from untransfected and GFP-L22 transfected 293T cells were analyzed by immunblot using anti-L22 and
anti-GAPDH antibodies. Extract from the indicated number of cells was analyzed. Following detection of L22, blots were stripped of antibody and
reprobed for GAPDH which served as a control for cytoplasmic contamination of nuclear extracts. (C) Localization of endogenous L22 and GFP-L22 in
HeLa-L22 cells was assessed by sucrose density gradient analysis. Ribosome-containing lysates were separated on a 10–50% w/v sucrose gradient and
0.5 ml fractions were collected from the top of the gradient. The protein and RNA content of each fraction was analyzed by western blot and agarose
gel electrophoresis, respectively. Total RNA was visualized by ethidium bromide. Polysome profiles were recorded during fraction collection at
260 nm. The ribosomal subunit composition of each peak is indicated along with fraction numbers corresponding to the first and last fraction
collected (1 and 12) as well as the start of collection of the 40S (fraction 6) and 60S (fraction 9) peaks.
doi:10.1371/journal.pone.0005306.g005
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retention of L22 in nucleoli (Fig. 6A: m88, m88A and m80–93).
Furthermore, sucrose density gradient fractionation of a 293T cell
line engineered to stably express m88 (Fig. 6B) revealed that the
majority of m88 was found at the top of the gradient (fractions 1–
3), as demonstrated by western blot analysis using both anti-L22
and anti-GFP antibodies (Fig. 6B, upper and middle panels). This
fractionation pattern is distinct from that seen with endogenous
L22 and wild-type GFP-L22 (Fig. 6B, fractions 9–12, top panel) in
that unlike these proteins, m88 did not co-fractionate with 28S
rRNA (found in fractions 9–12) and was not incorporated into
ribosomal subunits. Consistent with our hypothesis, proteins with
mutations in residues 80–84 (m80, m80A), which maintained some
residual RNA binding capacity (Fig. 4B), also showed an
intermediate pattern of localization in which L22 was mainly
relocalized to the nucleoplasm with a small fraction of L22
retained in nucleoli. m65, a protein which is capable of binding
RNA, showed two distinct patterns of localization. While a
fraction of m65 localizes to nucleoli, a significant percent is found
in dense precipitates within nuclei in a subpopulation of cells
(Fig. 6A). As discussed above, transfection of m65 results in lower
levels of protein expression relative to the other L22 constructs and
may be somewhat cytotoxic in the subpopulation of cells
containing these aggregates. These fluorescence localization and
fractionation studies, together with the results of our RNA-binding
studies, provide strong support for our hypothesis that interaction
of L22 with 28S rRNA is a key determinant of nucleolar
localization of L22.
Discussion
Previous studies investigating the interaction between L22 and
RNA have focused on defining the specific nucleotides required
for L22 binding [19,25–27]. Here, we have focused instead on
defining the amino acid residues of L22 that contribute to its RNA
binding capacity using two RNAs that match the binding site
consensus previously defined by Dobbelstein and Shenk [25]. Our
data establish that basic amino acids spanning 88–93 are critical
for RNA binding by L22 and support a role for a second cluster of
basic amino acids, 80–84, in high affinity RNA binding (Figs. 3
Figure 6. Mutation of residues 80–93 alters the subcellular localization of L22 and prevents incorporation into ribosomes. (A) The
subcellular localization of mutated GFP-L22 proteins was analyzed by fluorescence microscopy following transient expression in 293T cells as
described in Fig. 5A. (B) Incorporation of m88 into ribosomes was analyzed by sucrose density gradient analysis of extracts generated from 293T cells
engineered to stably express m88, as described in Fig. 5B. Migration of molecular weight standards (in kDa) is indicated to the left of the blots.
Following detection of L22 (15 kDa) and m88 (43 kDa) with anti-L22 antibody, the blot was stripped of antibody and reprobed with anti-GFP
antibody to confirm that the 43 kDa bands present in fractions 1–3 were in fact GFP-tagged L22.
doi:10.1371/journal.pone.0005306.g006
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targeting of L22 to the nucleolus (Fig. 6) thereby linking RNA
binding and nucleolar localization.
Using a biotin-avidin affinity assay to confirm the in vivo
interaction between L22 and the RNAs used in our subsequent in
vitro binding assays, we observed strong binding of L22 to EBER-1
and binding, albeit significantly weaker, to 28S rRNA (Fig. 1).
Binding of full-length 28S rRNA by L22 likely occurs in an
ordered cascade with multiple additional ribosomal proteins and
assembly factors. Once incorporated into a mature ribosomal
subunit, the biotinylated BAP tag of L22 may no longer be easily
accessible to the streptavidin beads used in this assay, resulting in
the observed weak binding. However, less efficient binding of L22
to 28S rRNA relative to EBER-1 has been previously reported
[25]. To identify the RNA-binding domain of L22, we evaluated a
number of amino acid residues for their contribution to RNA
binding in vitro (Fig. 2A). We focused primarily on internal clusters
of basic residues but also evaluated amino acids 1–9. These N-
terminal amino acids were chosen based on a previous report in
which deletion of these residues, along with the eight C-terminal
residues, prevented incorporation of L22 into 60S ribosomal
subunits [29]. As truncation of only the C-terminal residues did
not prevent incorporation, the authors predicted that the N-
terminal residues might play a role in rRNA binding. Our data
does not support this initial prediction as D1–9 did not differ from
full-length L22 in its RNA binding capacity (Figs. 3 and 4). We
instead found that amino acids 88–93 were absolutely required for
binding of L22 to both EBER-1 and 28S rRNA SL7. Further,
mutation of basic amino acids 80–84 eliminated binding of EBER-
1 and reduced, but did not completely eliminate, binding of 28S
rRNA (Fig. 4). Our data suggest that EBER-1 makes contact with
amino acids 80–84 as well as 88–93 whereas the contacts for SL7
are primarily between amino acids 88–93. As we only used SL7,
which represents a small portion of a much larger molecule, this
leaves open the possibility that additional nucleotide sequences of
28S rRNA not included in our assay interact directly with residues
80–84. SELEX experiments in which two nucleotide sequences of
28S rRNA in addition to SL7 were bound by L22 strongly support
this idea [25]. As no structural information for L22 is currently
available, it is difficult to discern whether this newly identified
RNA-binding domain conforms to any known RNA-binding
motif. Studies have shown, however, that the RNA-binding
domains of many ribosomal and nucleolar proteins appear to be
coincident with and have the characteristics of nucleolar
localization domains [14,16,35]. In light of this, we investigated
whether the RNA-binding domain of L22 is critical for its
nucleolar localization.
In agreement with Shu-Nu, et al., our results reveal that amino
acids 88–93 are necessary for the nucleolar localization of L22
[29]. In addition, amino acids 80–84 were found to contribute
significantly to nucleolar localization (Fig. 6A). A compact
nucleolar localization signal (NOS) consisting of a nucleolar
targeting sequence coincident with a nuclear localization signal
(NLS) has been previously defined [16]. This compact NOS was
shown to be sufficient for targeting a reporter protein to the
nucleolus. Such compact NOSs are found in a number of
ribosomal proteins including S25, S7 and L31 [7,10,11,16]. Other
ribosomal proteins, such as S19 and S6, require additional
sequences for nucleolar accumulation to occur [8,9]. To determine
whether amino acids 80–93 function as a compact NOS, we
evaluated the ability of a peptide containing only these residues to
direct GFP to the nucleolus. This peptide failed to target GFP to
the nucleolus demonstrating that amino acids 80–93 are not
sufficient to function as a compact NOS, at least in the context of
GFP (data not shown). In agreement with Shu-Nu, et al., we found
instead that the NLS of L22 is contained within amino acids 13–16
(Fig. 6A) [29]. In addition to the NLS located near the N-terminus,
Shu-Nu, et al. also proposed a role for the N-terminal and acidic
C-terminal domains in mediating the subcellular localization of
L22 [29]. We assessed the localization of L22 proteins truncated at
either the N- or C- terminus and found that truncation did not
alter the localization of L22 (Fig. 6A: D1–9 and D120–128; data
not shown). It should be noted that our constructs and
experimental design differ from those of Shu-Nu et al. in that
FLAG-tagged proteins and anti-FLAG immunofluorescence were
used by this group. We constructed and analyzed the localization
of multiple epitope-tagged full-length and D1–9 L22 construct
using immunofluorescence and obtained variable (different
localizations within a population of cells) and inconsistent results.
We attribute this to either problems associated with fixation of cells
or access of antibody to L22 incorporated in nucleoli. We
experience no such difficulties with either our GFP-tagged (N- or
C-terminal) or BAP-tagged proteins.
Our finding that amino acids 80–93 mediate both RNA binding
and nucleolar localization suggests that the nucleolar accumula-
tion of L22 is a consequence of its binding 28S rRNA. Such a link
between RNA binding and nucleolar accumulation is not novel. In
fact, many nucleolar proteins have been shown to contain RNA-
binding sites coincident with sequences critical for nucleolar
localization. These include Nop25, in which RNA binding is a
requisite for nucleolar localization, nucleolin, in which nucleolar
import is contingent upon two RNA-binding domains and p120,
in which the arginine-rich RNA-binding domain is coincident with
the NOS [35–37]. Furthermore, binding of rRNA was found to
mediate nucleolar localization of a number of ribosomal proteins
including S25, L5, and L7a [14,16,17]. It is not surprising that
sequences classified as NOSs are often discovered to contain RNA
binding activity since NOSs are generally rich in basic residues, a
feature amenable to binding negatively charged nucleic acids
[7,12,14,16]. These findings together with our data lead us to
conclude that the nucleolar localization of L22 is likely mediated
by its interaction with specific sequences of 28S rRNA.
As binding of both EBER-1 and 28S rRNA SL7 require the
same basic residues of L22 for binding, our data suggest that
binding of RNAs matching the consensus derived by Dobbelstein
and Shenk is mutually exclusive. This is substantiated by the
findings of Toczski et al. demonstrating that association of L22
with EBER-1 or the ribosome is mutually exclusive, implying
competition between RNA ligands [26]. Since rRNA binding is
linked to nucleolar accumulation, it might be speculated that
EBER-1 evolved to bind L22 during virus infection and prevent
accumulation of L22 in nucleoli. Indeed, it has been shown that
L22 is relocalized from nucleoli to the nucleoplasm in EBV-
infected cells [26]. Furthermore, other viral RNAs and proteins,
such as HCV 39X RNA, HVP-1 RNA and HSV ICP4 and ICP22
proteins, have been shown to interact with L22, raising the
possibility that L22 may play a central role during viral infection
[18,24,38,39]. This raises the question of whether these viruses
sequester L22 to prevent or modulate some cellular function of
L22 or whether L22 plays an active role in virus replication. As the
normal role of L22 remains essentially undefined it is difficult to
answer this question. L22 is not required for basal translation in
vitro nor is deletion of L22 in mice a lethal phenotype [20,22].
Interestingly, L22-deficient mice showed a selective block in ab T
cell development while cd T cells were unaffected. Together, this
suggests that L22 performs extra-ribosomal or regulatory functions
as have been described for multiple eukaryotic ribosomal proteins
(reviewed in: [40]). L22 is also known to interact with human
L22 RNA Binding Domain
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localize to nucleoli, this is not unexpected [41,42]. Given that hTR
and EBER-1 would likely be in competition for L22 binding in an
EBV-infected cell, one might predict that telomerase activity
would be altered in these cells if EBER-1 sequesters L22 as L22
traffics through the nucleoplasm to reach the nucleolus. Further-
more, use of mutants of L22 which have lost the capacity to bind
RNA would be predicted to alter telomerase activity as well as
potentially impact the nucleolar localization of hTR. Current and
future studies are aimed at characterizing the consequences of
relocalization of L22 during viral infection and tumorigenesis in an
effort to understand the role of L22 during these as well as normal
cellular processes.
Materials and Methods
Cell culture
293T and HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (Mediatech) supplemented with 4.5 g of glucose
per liter, 2 mM L-glutamine, 10% fetal bovine serum and 1%
penicillin/streptomycin. HeLa cells stably expressing GFP-L22
(HeLa-L22) were generated by FuGENE (Roche) transfection of
HeLa cells with pcDNA3.1-GFP-L22 and subsequent selection of
transfectants in media containing 600 mg G418 per ml. 293T cells
stably expressing m88 (293-m88) were generated by FuGENE
(Roche) co-transfection of 293T cells with pcDNA3.1-GFP-m88
and a hygromycin resistance plasmid, followed by subsequent
selection of transfectants in media containing 600 mg G418 and
200 mg hygromycin per ml.
Plasmids and site-directed mutagenesis
L22 cDNA was generated by reverse transcription PCR using total
RNA isolated from Akata Burkitt lymphoma cells. Primers used in
amplification were: 59-ATATGGATCCCCATGGCTCCTGT-39
and 59-GATCGAATTCCACTGACGAGATACAAGG-39. Ampli-
fied cDNA was digested with BamHI and EcoRI, then cloned into
digested pcDNA3 to generate pcDNA3-L22. This base construct was
used in subsequent PCR reactions to generate additional wild-type
and mutated L22 expression constructs. PCR amplified DNA
fragments were cloned into pcDNA3.1/NT-GFP-TOPO (Invitro-
gen) to generate N-terminal GFP fusion constructs. To generate L22-
GFP (C-terminal GFP fusion), L22 sequence was PCR amplified
from pcDNA3-L22 using primers which incorporated 59 BamHI and
39 EcoRI sites. GFP sequence was PCR amplified from pcDNA3.1/
NT-GFP using primers which incorporated 59 EcoRI and 39 XbaI
sites. Digested PCR products were cloned into BamHI and XbaI
digested pCR3.1, creating L22-GFP. The D1–9 deletion construct
was generated by PCR using the 59 primer: 59-AAGGGAGG-
CAAAAAAAAGAAGCAAGTTCTG-39along withthewild-type39
primer. Substitution mutants were generated via QuikChange site-
directed mutagenesis (Stratagene) followed by PCRamplification and
TOPO cloning. Specific amino acids altered to generate each
mutation are depicted in Fig. 2. GFP-L23 was a gift from H. Lu
(Indiana University School of Medicine). To generate the base BAP
vector(pCR3.1BAP),complementaryoligonucleotidescontainingthe
biotin acceptor peptide (BAP) sequence and the tobacco etch virus
protease (TEV) cleavage sites were annealed (59-AGCTTAT-
GAGCGGACTCAACGACATTTTCGAGGCCCAAAAGATC-
GAATGGCACGAAGAGAATCTGTACTTTCAGG-39 and 59-
GATCCCTGAAAGTACAGATTCTCTTCGTGCCATTCGAT-
CTTTTGGGCCTCGAAAATGTCGTTGAGTCCGCTCATA-
39) and ligated to HindIII and BamHI digested pCR3.1 (Invitrogen).
L22 sequence was PCR amplified from pcDNA3-L22 using primers
which incorporated 59 BamHI and 39 XbaIs i t e sa n dc l o n e di n t o
BamHI and XbaI digested pCR3.1BAP to create pCR3.1BAP-L22.
To generate pSG5-EBERs, the entire EBV EcoRI-J genomic
restriction fragment, containing both EBER-1 and EBER-2 and
their transcriptional regulatory elements, was ligated into EcoRI
digested pSG5 (Stratagene). pTER-EBER-1 and pTER-EBER-2
were generated by PCR amplification of the EBER-1 or EBER-2
coding sequence using primers incorporating 59 BamHI and 39
HindIII sites and cloned into BglII and HindIII digested pTER [43].
All plasmids were sequence verified and tested for correct expression
as described below.
Transfection and immunoblotting
To verify correct expression of GFP-tagged wild-type and
mutated L22, 293T cells were transiently transfected with 2 mgo f
each plasmid using FuGENE6 (Roche) according to the
manufacturer’s suggested protocol. 48 hrs post-transfection, cells
were harvested, washed in PBS and resuspended in lysis buffer
(50 mM Tris-Cl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, Complete
TM protease inhibitor cocktail [Roche])
followed by incubation on ice for 10 min. Insoluble material was
removed by centrifugation at 12,0006g for 10 min. The protein
concentration of the supernatant was determined by the Bradford
method. 30 mg total protein was fractionated on a 12% SDS-
PAGE gel, transferred onto Immobilon-P membrane (Millipore)
and processed using anti-GFP antibody (JL8 BD Living Colors,
Clontech).
RNA-binding assays
For MACS binding assays, linear templates for in vitro
transcription were generated by introducing a T7 promoter
upstream of the coding sequence of EBER-1 and stem-loop 7
(SL7) of 28S rRNA via PCR using the following primers: EBER: 59-
TAATACGACTCACTATAGGGACCTACGCTGCCC-39 and
59-AAAACATGCGGACCACCAGCT-39;2 8 S :5 9 TAATAC-
GACTCACTATAGGGAGTCGGGTTGCTTGGGAA-39 and
59-CGCCCTCTTGAACTCTC-39. In vitro transcription was
performed using the MEGAshortscript T7 kit (Ambion) according
to the manufacturer’s instructions. RNA-protein interaction was
assessed via streptavidin-labeled magnetic bead assay (MACS,
Miltenyi Biotec) in which EBER-1 RNA generated by in vitro
transcription was annealed to a biotinylated oligonucleotide (59-bio-
AAAACATGCGGACCACCAGCTGGTACT-39) complementa-
ry to the 39 end of EBER-1. 28S rRNA SL7 transcript was likewise
annealed (59-bio-CGCCCTCTTCTTCTCTCTCTTCAAAGT-
39). These biotinylated RNA-DNA hybrids were incubated with
protein lysate isolated from transiently transfected 293T cells and
bound complexes were captured on streptavidin-labeled magnetic
beads using mMACS columns. Column flow-thru, washes and
eluted bound protein were isolated and analyzed by immunoblot, as
described above.
For EMSA analyses, an RNA oligonucleotide corresponding to
n u c l e o t i d e s5 6t o8 7o fs t e m - l o o pI I Io fE B E R - 1w a se n d - l a b e l e dw i t h
[c-
32P] ATP using T4 polynucleotide kinase. Unincorporated
nucleotides were removed using NucAway columns (Ambion). Prior
to use, the probe was boiled for 3 min. and immediately placed on ice
for 3 min. 10 ml binding reactions containing 10 mM HEPES
(pH 8.0), 50 mM KCl, 1 mM EDTA, 0.1 mM DTT, 0.1% Triton
X-100, 2.5% glycerol, 1 mg yeast tRNA and protein lysate were
incubated on ice 10 min. prior to addition of 0.05 pmoles probe and
incubation on ice for an additional 20 min. Protein-RNA complexes
were resolved by electrophoresis in non-denaturing 8% polyacryl-
amide gels run at 4uCi n0 . 5 6TBE or TTE (National Diagnostics).
Following electrophoresis, gels were dried and processed by
autoradiography. Antibody supershifts were used to assess binding
L22 RNA Binding Domain
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after the addition of probe. Competition experiments utilized 106
and 1006molar excess of either unlabeled EBER-1 SL3 or mutated
SL3 (59-CACCCGGCCAUGGUACAAGGCCAUGGUGGUGA-
39) RNA oligonucleotides added 10 min. prior to the addition of
probe.
To generate in vivo biotinylated BAP-L22 in the presence of
EBERs for biotin-avidin affinity assays, 293T cells were co-
transfected with 1 mg each pBirA biotin ligase (provided by Dr.
Adam Geballe), pCR3.1BAP-L22 and EBER expression constructs
in the presence of 25 mM biotin. 48 hrs post-transfection, cells were
UV irradiated on ice for 4.5 min. (254 nM) and lysed in 500 ml
NET-N (50 mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA,
0.5% NP-40, Complete
TM protease inhibitor cocktail [Roche]).
Following centrifugation to pellet cell debris, lysates were mixed
with100 ml immobilized avidinbeads (Pierce)and rockedat 4uC for
1 hour. Beads were pelleted, separated from the supernatant,
washed 56with NET-N and resuspended in 300 ml elution buffer
(100 mM Tris [pH 8.0], 150 mM NaCl, 1% SDS, 12.5 mM
EDTA) followed by heating at 65uC for 15 min. RNA from the
supernatant and bound fractions was extracted with phenol-
chloroform and ethanol precipitated. Total bound RNA and
2.5 mg supernatant RNA were loaded onto a 1.2% agarose-2.2 M
formaldehyde gel and processed by northern hybridization using
standard protocols. Verification of biotinylated BAP-L22 isolation
was accomplished as above except that beads were resuspended in
26SDS loading dye and electrophoresed on a tricine peptide gel
followed by immunoblot analysis using anti-L22 (BD Transduction
Laboratories) and HRP-conjugated streptavidin (Vector Labs).
Fluorescence localization
293T cells were seeded into 60 mm tissue culture dishes
containing coverslips and transiently transfected with GFP-tagged
wild-type or mutated L22 expression constructs using FuGENE6
(Roche) as described above. 48 hrs post-transfection, coverslips
were washed in PBS and fixed 10 min. in cold methanol followed
by 10 min. in cold acetone. HeLa-L22 cells were seeded as above
and fixed in 4% paraformaldehyde for 10 min. followed by 0.25%
Triton X-100 for 10 min. BAP-L22 was visualized by staining with
Alexa Fluor 488-conjugated streptavidin (Molecular Probes).
Fibrillarin was detected using anti-fibrillarin antibody (Abcam
Ab4566) and Alexa Fluor 568-conjugated anti-mouse secondary
antibody. Coverslips were mounted in Vectashield plus DAPI
(Vector Laboratories) and fluorescence visualized using a Zeiss
Axiovert inverted fluorescence microscope.
Isolation of nuclear and cytoplasmic extracts
Extracts from untransfected and transiently GFP-L22 transfect-
ed 293T cells were generated using the NE-PERH kit (Pierce) as
per the manufacturers’ instructions. Extracts from 1–4610
5 cells
were electrophoresed on a tricine peptide gel and immunoblotted
using anti-L22 antibody as described above. The integrity of the
nuclear and cytoplasmic fractions was assessed by immunoblotting
using anti-GAPDH antibody (Imgenex).
Sucrose density gradient analyses
Ribosome containing lysates were prepared using a protocol
adapted from Arava, et al., 2003 [44]. Cells were treated with
0.1 mg/ml cycloheximide for 3–5 min at 37uC, pelleted by
centrifugation, washed in PBS and resuspended at a density of
3–8610
7 cells per ml in ribosome lysis buffer (20 mM Tris,
[pH 8.0], 140 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 1%
Triton X-100, 0.1 mg/ml cycloheximide). Lysates were homog-
enized on ice using a dounce homogenizer and tight pestle.
Following centrifugation for 10 minutes at 12,0006g, lysates were
overlaid onto a 10–50% (w/v) sucrose gradient prepared by
overlaying 10% buffered sucrose (20 mM Tris [pH 8.0], 140 mM
KCl, 5 mM MgCl2, 0.5 mM DTT, 0.1 mg/ml cycloheximide)
onto 50% buffered sucrose followed by horizontal diffusion for
3 hours. Gradients were centrifuged at 35K RPM in an SW41
rotor for 160 min at 4uC. 0.5 ml fractions were collected using an
Isco fractionator and Foxy Jr. fraction collector. Fractions were
divided into 2 aliquots for subsequent RNA and protein analysis.
Total RNA from gradient fractions was prepared by phenol-
chloroform extraction and ethanol precipitation. RNA was
fractionated by electrophoresis through a 1.2% agarose gel and
visualized by ethidium bromide staining. Protein was prepared
from gradient fractions by TCA precipitation using Na-deoxy-
cholate (125 ug/ml) and trichloroacetic acid (6%). Following
incubation on ice for 15 min and centrifugation, pellets were
washed 26 with cold acetone, resuspended in 16 SDS loading
buffer and loaded onto tricine peptide gels. Proteins were
transferred onto Immobilon-P membrane (Millipore) and immu-
noblotted using an enhanced chemiluminescent detection system
(HyGLO, Denville Scientific). Primary antibodies utilized were:
anti-L22 (BD Transduction Labs) and anti-GFP (JL8 BD Living
Colors, Clontech). Immunoreactive proteins were detected using
HRP-conjugated secondary antibodies. For reprobing, mem-
branes were stripped of antibody in stripping buffer (62.5 mM
Tris-Cl [pH 6.8], 100 mM 2-mercaptoethanol, 2% SDS) for
30 min at 50uC.
Acknowledgments
We thank A. Geballe and H. Lu for providing reagents; N. Morrissette for
valuable advice and use of the microscope; Kerry Fitzgerald for advice on
sucrose gradient fractionation; B. Semler and H. Fan for helpful
discussions.
Author Contributions
Conceived and designed the experiments: JLH IKR. Performed the
experiments: JLH. Analyzed the data: JLH IKR. Wrote the paper: JLH
IKR.
References
1. Melese T, Xue Z (1995) The nucleolus: an organelle formed by the act of
building a ribosome. Current Opinion in Cell Biology 7: 319–324.
2. Olson MO, Dundr M (2005) The moving parts of the nucleolus. Histochem Cell
Biol 123: 203–216.
3. Dingwall C, Laskey RA (1991) Nuclear targeting sequences–a consensus?
Trends Biochem Sci 16: 478–481.
4. Chelsky D, Ralph R, Jonak G (1989) Sequence requirements for synthetic
peptide-mediated translocation to the nucleus. Mol Cell Biol 9: 2487–
2492.
5. Stuger R, Timmers AC, Raue HA, Riet J (2000) Nuclear Import of Ribosomal
Proteins: Evidence for a Novel Type of Nuclear Localization Signal. In:
Garrett RA, Douthwaite SR, Liljas A, Matheson AT, Moore PB, et al. eds. The
Ribosome: Structure, Function, Antibiotics, and Cellular Interactions. Wa-
shington, D.C.: ASM Press. pp 205–214.
6. Hatanaka M (1990) Discovery of the nucleolar targeting signal. Bioessays 12:
143–148.
7. Annilo T, Karis A, Hoth S, Rikk T, Kruppa J, et al. (1998) Nuclear import and
nucleolar accumulation of the human ribosomal protein S7 depends on both a
minimal nuclear localization sequence and an adjacent basic region. Biochem
Biophys Res Commun 249: 759–766.
8. Da Costa L, Tchernia G, Gascard P, Lo A, Meerpohl J, et al. (2003) Nucleolar
localization of RPS19 protein in normal cells and mislocalization due to
mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia
patients: potential insights into pathophysiology. Blood 101: 5039–5045.
L22 RNA Binding Domain
PLoS ONE | www.plosone.org 10 April 2009 | Volume 4 | Issue 4 | e53069. Schmidt C, Lipsius E, Kruppa J (1995) Nuclear and nucleolar targeting of
human ribosomal protein S6. Mol Biol Cell 6: 1875–1885.
10. Timmers AC, Stuger R, Schaap PJ, van’t Riet J, Raue HA (1999) Nuclear and
nucleolar localization of Saccharomyces cerevisiae ribosomal proteins S22 and
S25. FEBS Lett 452: 335–340.
11. Quaye IK, Toku S, Tanaka T (1996) Sequence requirement for nucleolar
localization of rat ribosomal protein L31. Eur J Cell Biol 69: 151–155.
12. Kundu-Michalik S, Bisotti MA, Lipsius E, Bauche A, Kruppa A, et al. (2008)
Nucleolar binding sequences of the ribosomal protein S6e family reside in
evolutionary highly conserved peptide clusters. Mol Biol Evol 25: 580–590.
13. Lipsius E, Walter K, Leicher T, Phlippen W, Bisotti MA, et al. (2005)
Evolutionary conservation of nuclear and nucleolar targeting sequences in yeast
ribosomal protein S6A. Biochem Biophys Res Commun 333: 1353–1360.
14. Rosorius O, Fries B, Stauber RH, Hirschmann N, Bevec D, et al. (2000) Human
ribosomal protein L5 contains defined nuclear localization and export signals.
J Biol Chem 275: 12061–12068.
15. Michael WM, Dreyfuss G (1996) Distinct domains in ribosomal protein L5
mediate 5 S rRNA binding and nucleolar localization. J Biol Chem 271:
11571–11574.
16. Kubota S, Copeland TD, Pomerantz RJ (1999) Nuclear and nucleolar targeting
of human ribosomal protein S25: common features shared with HIV-1
regulatory proteins. Oncogene 18: 1503–1514.
17. Russo G, Cuccurese M, Monti G, Russo A, Amoresano A, et al. (2005)
Ribosomal protein L7a binds RNA through two distinct RNA-binding domains.
Biochem J 385: 289–299.
18. Toczyski DP, Steitz JA (1991) EAP, a highly conserved cellular protein
associated with Epstein-Barr virus small RNAs (EBERs). Embo J 10: 459–466.
19. Toczyski DP, Steitz JA (1993) The cellular RNA-binding protein EAP
recognizes a conserved stem-loop in the Epstein-Barr virus small RNA EBER
1. Mol Cell Biol 13: 703–710.
20. Lavergne JP, Conquet F, Reboud JP, Reboud AM (1987) Role of acidic
phosphoproteins in the partial reconstitution of the active 60 S ribosomal
subunit. FEBS Lett 216: 83–88.
21. Matsson H, Davey EJ, Draptchinskaia N, Hamaguchi I, Ooka A, et al. (2004)
Targeted disruption of the ribosomal protein S19 gene is lethal prior to
implantation. Mol Cell Biol 24: 4032–4037.
22. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, et al.
(2007) Ablation of ribosomal protein L22 selectively impairs alphabeta T cell
development by activation of a p53-dependent checkpoint. Immunity 26:
759–772.
23. Le S, Sternglanz R, Greider CW (2000) Identification of two RNA-binding
proteins associated with human telomerase RNA. Mol Biol Cell 11: 999–1010.
24. Wood J, Frederickson RM, Fields S, Patel AH (2001) Hepatitis C virus 39X
region interacts with human ribosomal proteins. J Virol 75: 1348–1358.
25. Dobbelstein M, Shenk T (1995) In vitro selection of RNA ligands for the
ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by
using randomized and cDNA-derived RNA libraries. J Virol 69: 8027–8034.
26. Toczyski DP, Matera AG, Ward DC, Steitz JA (1994) The Epstein-Barr virus
(EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-
infected human B lymphocytes. Proc Natl Acad Sci U S A 91: 3463–3467.
27. Fok V, Mitton-Fry RM, Grech A, Steitz JA (2006) Multiple domains of EBER 1,
an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22.
Rna 12: 872–882.
28. Michot B, Hassouna N, Bachellerie JP (1984) Secondary structure of mouse 28S
rRNA and general model for the folding of the large rRNA in eukaryotes.
Nucleic Acids Res 12: 4259–4279.
29. Shu-Nu C, Lin CH, Lin A (2000) An acidic amino acid cluster regulates the
nucleolar localization and ribosome assembly of human ribosomal protein L22.
FEBS Lett 484: 22–28.
30. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ (1991) Binding
of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated
protein kinase DAI. Nucleic Acids Res 19: 243–248.
31. Fok V, Friend K, Steitz JA (2006) Epstein-Barr virus noncoding RNAs are
confined to the nucleus, whereas their partner, the human La protein, undergoes
nucleocytoplasmic shuttling. J Cell Biol 173: 319–325.
32. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded
by Epstein-Barr virus and complexed with protein are precipitated by antibodies
from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78:
805–809.
33. Carmo-Fonseca M, Mendes-Soares L, Campos I (2000) To be or not to be in the
nucleolus. Nat Cell Biol 2: E107–112.
34. Shaw PJ, Jordan EG (1995) The nucleolus. Annu Rev Cell Dev Biol 11: 93–121.
35. Schmidt-Zachmann MS, Nigg EA (1993) Protein localization to the nucleolus: a
search for targeting domains in nucleolin. J Cell Sci 105 (Pt 3): 799–806.
36. Fujiwara T, Suzuki S, Kanno M, Sugiyama H, Takahashi H, et al. (2006)
Mapping a nucleolar targeting sequence of an RNA binding nucleolar protein,
Nop25. Exp Cell Res 312: 1703–1712.
37. Gustafson WC, Taylor CW, Valdez BC, Henning D, Phippard A, et al. (1998)
Nucleolar protein p120 contains an arginine-rich domain that binds to
ribosomal RNA. Biochem J 331 (Pt 2): 387–393.
38. Leopardi R, Roizman B (1996) Functional interaction and colocalization of the
herpes simplex virus 1 major regulatory protein ICP4 with EAP, a nucleolar-
ribosomal protein. Proc Natl Acad Sci U S A 93: 4572–4576.
39. Leopardi R, Ward PL, Ogle WO, Roizman B (1997) Association of herpes
simplex virus regulatory protein ICP22 with transcriptional complexes
containing EAP, ICP4, RNA polymerase II, and viral DNA requires
posttranslational modification by the U(L)13 proteinkinase. J Virol 71:
1133–1139.
40. Wool IG (1996) Extraribosomal functions of ribosomal proteins. Trends
Biochem Sci 21: 164–165.
41. Mitchell JR, Cheng J, Collins K (1999) A Box H/ACA Small Nucleolar RNA-
Like Domain at the Human Telomerase RNA 39 End. Mol Cell Biol 19:
567–576.
42. Narayanan A, Lukowiak A, Jady BE, Dragon F, Kiss T, et al. (1999) Nucleolar
localization signals of box H/ACA small nucleolar RNAs. Embo J 18:
5120–5130.
43. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, et al.
(2003) Specific inhibition of gene expression using a stably integrated, inducible
small-interfering-RNA vector. EMBO Rep 4: 609–615.
44. Arava Y (2003) Isolation of polysomal RNA for microarray analysis. Methods
Mol Biol 224: 79–87.
L22 RNA Binding Domain
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5306